For: | Triantafillidis JK, Zografos CG, Konstadoulakis MM, Papalois AE. Combination treatment of inflammatory bowel disease: Present status and future perspectives. World J Gastroenterol 2024; 30(15): 2068-2080 [PMID: PMC11045479 DOI: 10.3748/wjg.v30.i15.2068] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v30/i15/2068.htm |
Number | Citing Articles |
1 |
Antonio M Caballero-Mateos, Guillermo Arturo Cañadas-de la Fuente. Game changer: How Janus kinase inhibitors are reshaping the landscape of ulcerative colitis management. World Journal of Gastroenterology 2024; 30(35): 3942-3953 doi: 10.3748/wjg.v30.i35.3942
|
2 |
Alexandra Olate-Briones, Sofía Albornoz-Muñoz, Francisca Rodríguez-Arriaza, Valentina Rodríguez-Vergara, Juan Machuca Aguirre, Chaohong Liu, Carlos Peña-Farfal, Noelia Escobedo, Andrés A. Herrada. Yerba Mate (Ilex paraguariensis) Reduces Colitis Severity by Promoting Anti-Inflammatory Macrophage Polarization. Nutrients 2024; 16(11): 1616 doi: 10.3390/nu16111616
|
3 |
Wen-Ting Xie, Hui Yang, Lan Bai, Feng-Fei Wu. New perspectives and prospects for the next generation of combination therapy in inflammatory bowel disease. World Journal of Gastroenterology 2025; 31(5): 99462 doi: 10.3748/wjg.v31.i5.99462
|
4 |
Lucia Centanni, Clelia Cicerone, Fabrizio Fanizzi, Ferdinando D’Amico, Federica Furfaro, Alessandra Zilli, Tommaso Lorenzo Parigi, Laurent Peyrin-Biroulet, Silvio Danese, Mariangela Allocca. Advancing Therapeutic Targets in IBD: Emerging Goals and Precision Medicine Approaches. Pharmaceuticals 2025; 18(1): 78 doi: 10.3390/ph18010078
|
5 |
Pengfei Zhang, Bing Pei, Chengxue Yi, Francis Atim Akanyibah, Fei Mao. The role of suppressor of cytokine signaling 3 in inflammatory bowel disease and its associated colorectal cancer. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2025; 1871(2): 167578 doi: 10.1016/j.bbadis.2024.167578
|
6 |
Kristyna Gabova, Hana Bednarikova, Zdenek Meier, Peter Tavel. Exploring intimacy and family planning in Inflammatory Bowel Diseases: a qualitative study. Annals of Medicine 2024; 56(1) doi: 10.1080/07853890.2024.2401610
|
7 |
Mouhaned Y. Al-darwesh, Karukh Ali Babakr, Ibrahim Nazem Qader, Mohammed A. Mohammed. Antimicrobial, anti-inflammatory, and anticancer potential of green synthesis TiO2 nanoparticles using Sophora flavescens root extract. Chemical Papers 2024; doi: 10.1007/s11696-024-03853-0
|
8 |
Ya-Xiong Guo, Xiong Yan, Xu-Chang Liu, Yu-Xiang Liu, Chun Liu. Artificial intelligence-driven strategies for managing renal and urinary complications in inflammatory bowel disease. World Journal of Nephrology 2025; 14(1): 100825 doi: 10.5527/wjn.v14.i1.100825
|
9 |
Jeffrey A Lowell, Michael J Farber, Keith Sultan. Back to the drawing board: Overview of the next generation of combination therapy for inflammatory bowel disease. World Journal of Gastroenterology 2024; 30(25): 3182-3184 doi: 10.3748/wjg.v30.i25.3182
|
10 |
Barbara Macura, Aneta Kiecka, Marian Szczepanik. Intestinal permeability disturbances: causes, diseases and therapy. Clinical and Experimental Medicine 2024; 24(1) doi: 10.1007/s10238-024-01496-9
|
11 |
Andrzej S Tarnawski. Editor-in-Chief articles of choice and comments from January to June 2024. World Journal of Gastroenterology 2024; 30(34): 3875-3882 doi: 10.3748/wjg.v30.i34.3875
|
12 |
Lakshmi Thangavelu, Syam Mohan, Hassan A. Alfaifi, Abdullah Farasani, Soumya V. Menon, Pooja Bansal, Chhavi Choudhary, M Ravi Kumar, Raghav Vashishth, Afrah M.A. Al- Rihaymee, Sarvesh Rustagi, Anil K. Malhotra, Muhammed Shabil, Mahalaqua N. Khatib, Quazi S. Zahiruddin, Siddig I. Abdelwahab, Ganesh Bushi, Saleh H.A. Almasabi, Hayam A. Alrasheed, Ali A. Rabaan. Safety and efficacy of stem cell therapy for Crohn’s disease: an umbrella review of systematic reviews. International Journal of Surgery 2024; 110(12): 7495 doi: 10.1097/JS9.0000000000002104
|